Skip to main content
AMP 2023 Main banner
Back

General Session

Session 10: New Data & Late Breaking Trials

Friday, August 18, 2023
10:30 AM – 12:00 PM CT
Location:Chicago Ballroom

Presentations:

  • 10:30 AM – 10:37 AM CT
    Predictors of Quality of Life Post-PVI in CLI vs Claudicant Patients

    Speaker: Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI, FSVM – Beth Israel Deaconess Medical Center, Harvard Medical School

  • 10:37 AM – 10:44 AM CT
    Real World Evidence of Stellarex DCB for the Treatment of Infrainguinal Disease: 12-Month Results from the Stellarex Vascular E-Registry (SVER) in Complex Patients.

    Speaker: Marianne Brodmann, MD – Division of Angiology Medical University Graz

  • 10:44 AM – 10:51 AM CT
    Percutaneous Bypass for Treatment of Femoropopliteal Disease in Office-Based Labs: DETOUR-2 Procedural Experience Across Clinical Settings

    Speaker: Fadi Saab, MD – ACV Centers

  • 10:51 AM – 10:58 AM CT
    A Pooled Sub-Analysis of the TOBA II and TOBA III Studies: Dissection Repair in Lesions with Moderate-to-Severe Calcium

    Speaker: Marianne Brodmann, MD – Division of Angiology Medical University Graz

  • 10:58 AM – 11:05 AM CT
    Current Clinical Data on RANGER DCB: RANGER II SFA, COMPARE and Real-World Experience with ELEGANCE

    Speaker: Pradeep K. Nair, MD, FACC, FSCAI – Cardiovascular Institute of the South

  • 11:05 AM – 11:12 AM CT
    A Patient-Level Pooled Analysis of DCBs vs BMS for the Treatment of Symptomatic Femoropopliteal Diease

    Speaker: Thomas Zeller, MD – Angiology Universitaets-Herzzentrum Freiburg - Bad Krozingen

  • 11:12 AM – 11:19 AM CT
    Predictors of DCB Efficacy in Femoropopliteal Intervention: Insights from a Patient-Level Pooled Analysis

    Speaker: Thomas Zeller, MD – Angiology Universitaets-Herzzentrum Freiburg - Bad Krozingen

  • 11:19 AM – 11:26 AM CT
    One Year Results of the DEEPER LIMUS Trial: The Bare Temporary Spur Stent System in Conjunction with a Sirolimus-Coated Balloon

    Speaker: Marianne Brodmann, MD – Division of Angiology Medical University Graz

  • 11:26 AM – 11:33 AM CT
    When is the VenaSeal Closure System Appropriate for Patients with Ulcers and combined Arterial and Venous Disease?

    Speaker: Michael Shao, MD, RPVI – Swedish Hospital, Northshore University HealthSystem

  • 11:33 AM – 11:40 AM CT
    Six and 12-Month Results from a Prospective Study of the Aspirex Endovascular Thrombectomy System for the Treatment of Acute Venous Occlusions

    Speaker: Michael K.W Lichtenberg – Vascular Center Arnsberg, Germany

  • 11:40 AM – 11:47 AM CT
    SELUTION SLR Siroliimus-eluting Balloon in CLI - Latest Results and Ongoing Clinical Trials

    Speaker: Marianne Brodmann, MD – Division of Angiology Medical University Graz

  • 11:47 AM – 11:54 AM CT
    Clinical Trial Update on Eluvia DES: EMINENT RCT vs BMS, REGAL Registry and Long-Term Data from IMPERIAL RCT

    Speaker: Peter Soukas, MD, FACC, FSVM, FSCAI, FACP – Brown Medical School/Cardiovascular Institute

  • 11:54 AM – 12:00 PM CT
    Update on the Primary Endpoints of the DEEPER OUS Trial: the Bare Temporary Spur Stent System in Conjunction with a Paclitaxel-Coated Balloon

    Speaker: Jos C. van den Berg, MD PhD – Ospedale Regionale di Lugano, sede Civico